Lecozotan Hydrochloride is a selective 5-HT1A receptor antagonist that has been investigated for the treatment of Alzheimer's disease, particularly for its potential to enhance cognitive function and memory.… Read more
Lecozotan Hydrochloride is a selective 5-HT1A receptor antagonist that has been investigated for the treatment of Alzheimer's disease, particularly for its potential to enhance cognitive function and memory. This category offers high-quality reference standards of Lecozotan Hydrochloride, alongside a comprehensive selection of its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials are essential tools for pharmaceutical laboratories engaged in rigorous analytical testing and quality control. By utilizing these precise reference standards, researchers can perform accurate impurity profiling and method validation, ensuring compliance with regulatory standards throughout the drug development lifecycle. The inclusion of stable isotope-labelled compounds further supports the development of reliable mass spectrometry assays, facilitating the sensitive and specific quantification of the drug and its related substances in complex matrices.